Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia
Journal of Small Animal Practice · 2024
DOI: 10.1111/jsap.13700 ↗At a glance
Journal article in Journal of Small Animal Practice, 2024. Written by E Stikeman and 1 co-authors. Institution: Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA. Major MEDLINE topics: Dog Diseases, Immunoglobulins, Intravenous, Neoplasms. Cited 1 times so far (Crossref); 62 references.
Abstract (original language)
Objectives To evaluate the safety and efficacy of human intravenous immunoglobulin in dogs with newly diagnosed malignancy and presumed secondary immune‐mediated thrombocytopenia. Materials and Methods Twelve client‐owned dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia were prospectively enrolled to receive a single infusion of human intravenous immunoglobulin at a dose of 0.5 to 1 mg/kg intravenous over 8 hours. A complete treatment response was defined as a platelet estimation of ≥40,000 platelets/μL within 24 hours and a partial response within 48 hours from the completion of human intravenous immunoglobulin infusion. No treatment response was defined as a platelet estimation remaining
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA.
Cite
APA
Stikeman, E., & Bianco, D. (2024). Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13700
Vancouver
Stikeman E, Bianco D. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13700
BibTeX
@article{Stikeman2024,
author = {Stikeman, E and Bianco, D},
title = {Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia},
journal = {Journal of Small Animal Practice},
year = {2024},
doi = {10.1111/jsap.13700}
}
EUVIMED